Adaptimmune Therapeutics PLC (ADAPY) › Shares OutstandingAdaptimmune Therapeutics PLC (ADAPY) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 424.71M2016: 424.78M2017: 562.12M2018: 627.45M2019: 631.00M2020: 928.75M2021: 928.55M2022: 987.11M2023: 1.36B2024: 1.54B1.54B2015Shares Outstanding (shares)2024Fiscal YearShares OutstandingChange YoY20241.54B+12.7%20231.36B+38.1%2022987.11M+6.3%2021928.55M-0.0%2020928.75M+47.2%2019631.00M+0.6%2018627.45M+11.6%2017562.12M+32.3%2016424.78M+0.0%2015424.71M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share